Training Intervention in a Controlled Population of Frail Elderly
EMTIFE
Effect of a Multicomponent Training Intervention on Cognition, Mood, and Function in a Controlled Population of Community-dwelling Frail Elderly Patients.
1 other identifier
interventional
100
1 country
1
Brief Summary
Exercise has a beneficial role in geriatric patients categorized as frail. Nevertheless, it is not known physical training pattern more beneficial for these patients. The reasons for heterogeneity and lack of consistency of the results described by published intervention programs may be the diversity of isolated - resistance, endurance or proprioceptive trainings - or a combination of them. There are no studies with a combined program of this three kinds of physical training. The objective of this study is to know if a multicomponent physical training program during 180 days in dwelling-community frail geriatric patients can improve scores on functional, activities of daily living, mood, cognitive and quality of life scales and producing changes in blood levels of biological and genetic markers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 3, 2015
CompletedFirst Posted
Study publicly available on registry
January 6, 2015
CompletedFebruary 3, 2015
January 1, 2015
1.1 years
January 3, 2015
January 31, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Activities of daily living.
The primary study endpoint is the change from baseline to the end of the intervention, and the change between the intervention group and the control group, in score of Barthel Activities of Daily Living Index and the Lawton Instrumental Activities of Daily Living Scale
Day 0 and Day 180 (plus or minus 3 days)
Secondary Outcomes (2)
Mini-Mental State Examination (MMSE)
Day 0 and Day 180 (plus or minus 3 days)
Short Physical Performance Battery and Physical Performance Test
Day 0 and Day 180 (plus or minus 3 days)
Other Outcomes (3)
Geriatric Depression Scale
Day 0 and Day 180 (plus or minus 3 days)
Quality of life: EuroQol-5D
Day 0 and Day 180 (plus or minus 3 days)
Composite effect of a multicomponent training intervention on systemic biomarkers of frailty
Day 0 and Day 180 (plus or minus 3 days)
Study Arms (2)
Intervention group
EXPERIMENTALMulticomponent training intervention : 3 sessions a week of 45 minutes of resistance activity (24 weeks) 2 sessions a week of 45 minutes of strength training (24 weeks) 5 sessions a week of 15 minutes of proprioceptive training (24 weeks)
Control group
PLACEBO COMPARATORNormal routine during 24 weeks.
Interventions
Intervention characteristics: 24weeks, 5days/week, 60min/session Day 1, 3 and 5 15 min (a) 40 min (b) 5 min (d) Day 2 and 4 15 min (a) 40 min (c) 5 min (d) Legend: min. =minutes a = Proprioception exercises, postural sway and dynamic balance, coordination and flexibility of the lumbo-pelvic area b = Aerobic training 65% maximal Heart rate c = Strength training arms and legs d = Stretching
Enrolled patients will receive nutritional information on optimal daily energy intake, ensuring at least a daily protein intake of 1 g. of by kg of weight. Calcium plus vitamin D (total amount 1200 mg calcium plus 800 IU of vitamin D) Vitamin D will be provided if calcidiol (Cldl) blood levels are lower than 30 ng/ml. Cldl 20-29 ng/dl it will provide calciferol 20.000 IU every 15 days (3 months) Cldl 10-19 ng/dl it will provide calciferol 20.000 IU every 10 days (3 months) Cldl 1-9 ng/dl it will provide calciferol 20.000 IU every 7 days (3 months)
Eligibility Criteria
You may qualify if:
- \- Dwelling-community subjects
- \- Age 70 years old and older
- Frail geriatric patient according to the Cardiovascular Health Study (CHS) Frailty Phenotype
- Gait speed less than 0.8 m/s.
You may not qualify if:
- \- Life expectancy less than 6 months for any clinical reason (we considered criteria of a life expectancy less than 6 months 7 c-7 d global deterioration degree on GDS (Global Deterioration Scale)-FAST (Functional Assessment Staging ) scale in patients with dementia; severe disabilities considered as score less than 15 points in Barthel index and left ventricular ejection fraction equal or less than 20%)
- \- Hospital Admission in the last 3 months for any clinical reason
- \- oncologic patients in chemotherapy or radiotherapy active treatment
- \- Major surgery in the last 6 months
- \- First-degree centenary relatives in the two previous generations
- \- Ischemic coronary event in the last 12 months
- Institutionalized subjects
- Impossibility of displacement to the Health Center by themselves.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital de la Riberalead
- University of Valenciacollaborator
Study Sites (1)
Hospital Universitario de la Ribera
Alzira, Valéncia, 46600, Spain
Related Publications (1)
Tarazona-Santabalbina FJ, Gomez-Cabrera MC, Perez-Ros P, Martinez-Arnau FM, Cabo H, Tsaparas K, Salvador-Pascual A, Rodriguez-Manas L, Vina J. A Multicomponent Exercise Intervention that Reverses Frailty and Improves Cognition, Emotion, and Social Networking in the Community-Dwelling Frail Elderly: A Randomized Clinical Trial. J Am Med Dir Assoc. 2016 May 1;17(5):426-33. doi: 10.1016/j.jamda.2016.01.019. Epub 2016 Mar 3.
PMID: 26947059DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Pilar Pérez-Ros, PhD
Catholic University of Valencia San Vicente Mártir
- STUDY CHAIR
Francisco Martínez-Arnau, PhD
University of Valencia
- STUDY DIRECTOR
Jose Vina, MD,PhD
Univeristy of Valencia
- STUDY CHAIR
Carmen Gómez-Cabrera, PhD
University of Valencia
- PRINCIPAL INVESTIGATOR
Francisco J Tarazona-Santabalbina, MD, PhD
Hospital de la Ribera
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
January 3, 2015
First Posted
January 6, 2015
Study Start
December 1, 2013
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
February 3, 2015
Record last verified: 2015-01